Teva Looks To Acquire Japanese Generics Maker Taiyo

Fresh off announcing it would swoop in to acquire U.S. specialty pharma Cephalon Inc. for $6.8 billion, the world's largest generics player Teva Pharmaceutical Industries is now looking to acquire Taiyo Pharmaceutical Industry Co., Japan's third largest generics maker, for roughly ¥40 billion ($493.6 million), according to reports. Teva, which already has a joint venture with Kowa Co., a mid-tier Japanese pharma, will likely use Taiyo mainly for manufacturing and Teva-Kowa for sales